These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9988145)

  • 21. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The safety profile and antiviral activity of the combination of stavudine, didanosine, and nelfinavir in patients with HIV infection.
    Elion R; Kaul S; Knupp C; Adler M; Cross AP; Dunkle LM; Kelleher T
    Clin Ther; 1999 Nov; 21(11):1853-63. PubMed ID: 10890257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV-infected patients with low viral load: safety, efficacy and resistance profile after 144 weeks.
    Paton NI; Aboulhab J
    HIV Med; 2005 Jan; 6(1):13-20. PubMed ID: 15670247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy.
    Machado ES; Lambert JS; Watson DC; Afonso AO; da Cunha SM; Nogueira SA; Caride E; Oliveira RH; Sill AM; DeVico A; Tanuri A
    J Clin Virol; 2004 May; 30(1):24-31. PubMed ID: 15072750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.
    Landman R; Capitant C; Descamps D; Chazallon C; Peytavin G; Katlama C; Pialoux G; Bentata M; Brun-Vézinet F; Aboulker JP; Yéni P;
    J Antimicrob Chemother; 2009 Jul; 64(1):118-25. PubMed ID: 19420019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended antiretroviral treatment interruption in HIV-infected patients with long-term suppression of plasma HIV RNA.
    Achenbach CJ; Till M; Palella FJ; Knoll MD; Terp SM; Kalnins AU; Murphy RL
    HIV Med; 2005 Jan; 6(1):7-12. PubMed ID: 15670246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.
    Ruiz L; Paredes R; Gómez G; Romeu J; Domingo P; Pérez-Alvarez N; Tambussi G; Llibre JM; Martínez-Picado J; Vidal F; Fumaz CR; Clotet B;
    AIDS; 2007 Jan; 21(2):169-78. PubMed ID: 17197807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy.
    Wolbers M; Battegay M; Hirschel B; Furrer H; Cavassini M; Hasse B; Vernazza PL; Bernasconi E; Kaufmann G; Bucher HC;
    Antivir Ther; 2007; 12(6):889-97. PubMed ID: 17926643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recommendation of GESIDA (AIDS Study Group)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (I)].
    Miró JM; Antela A; Arrizabalaga J; Clotet B; Gatell JM; Guerra L; Iribarren JA; Laguna F; Moreno S; Parras F; Rubio R; Santamaría JM; Viciana P
    Enferm Infecc Microbiol Clin; 2000; 18(7):329-51. PubMed ID: 11109725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
    Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
    HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Resistance to antiretroviral drugs].
    Tamalet C; Yahi N; Koch N
    Med Trop (Mars); 1997; 57(2):121-6. PubMed ID: 9304001
    [No Abstract]   [Full Text] [Related]  

  • 33. [HIV infection].
    Tachikawa N
    Nihon Rinsho; 2006 Jul; 64(7):1333-7. PubMed ID: 16838653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiretroviral therapy: an update.
    Reddy P; Ross J
    Conn Med; 1998 Jan; 62(1):25-8. PubMed ID: 9509709
    [No Abstract]   [Full Text] [Related]  

  • 35. Dynamic Visual Display of Treatment Response in HIV-Infected Adults.
    Edwards JK; Cole SR; Martin JN; Moore R; Mathews WC; Kitahata M; Eron JJ; Saag M; Mugavero MJ;
    Clin Infect Dis; 2015 Jul; 61(1):e1-4. PubMed ID: 25838289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FHD: an index to evaluate drug elimination by hemodialysis.
    Launay-Vacher V; Izzedine H; Baumelou A; Deray G
    Am J Nephrol; 2005; 25(4):342-51. PubMed ID: 15980618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiretroviral rounds. Should we mess with success?
    J Watch AIDS Clin Care; 2009 Aug; 21(8):63-5. PubMed ID: 19795534
    [No Abstract]   [Full Text] [Related]  

  • 38. [Impact of new antiretroviral therapy in HIV infected patients with virologic failure].
    Costagliola D
    Med Sci (Paris); 2012; 28(8-9):706-7. PubMed ID: 22920871
    [No Abstract]   [Full Text] [Related]  

  • 39. Correlation between viral load measurements and outcome in clinical trials of antiviral drugs.
    Schooley RT
    AIDS; 1995 Dec; 9 Suppl 2():S15-S19. PubMed ID: 8775802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Removal of Dolutegravir by Hemodialysis in HIV-Infected Patients with End-Stage Renal Disease.
    Moltó J; Graterol F; Miranda C; Khoo S; Bancu I; Amara A; Bonjoch A; Clotet B
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2564-6. PubMed ID: 26856824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.